Skip to main content

Table 3 Primary outcome

From: Clinical advantages of a newly launched anti-thrombotic PMMA membrane for the nutritional status and dialysis-related symptoms in older chronic dialysis patients: a multicenter pilot study

 

n

0

3

6

9

12

NF group

15

5 (2–10)

6 (2–10)

7# (2–9)

7# (4–10)

6 (3–12)

Control group

14

5 (3–8)

5 (2–7)

5.5 (3–8)

6.5#,$ (2–10)

5.5& (2–9)

  1. Friedman test: #, p < 0.05 vs. baseline; $, p < 0.05 vs. 3 months; &, p < 0.05 vs. 9 months
  2. Results are presented as the median (minimum–maximum values)
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us